JPMorgan Chase Other Income (Expense) increased by 0.8% to $1.67B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 13.1%, from $1.92B to $1.67B. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 6.3% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.20B | $1.33B | $1.18B | $1.49B | $540.00M | $900.00M | $1.39B | $1.01B | $3.29B | $614.00M | $696.00M | $1.13B | $9.15B | $960.00M | $1.23B | $1.92B | $1.15B | $1.44B | $1.66B | $1.67B |
| QoQ Change | — | +11.5% | -11.4% | +26.3% | -63.8% | +66.7% | +54.7% | -27.7% | +226.9% | -81.3% | +13.4% | +62.1% | +711.1% | -89.5% | +27.6% | +57.0% | -40.0% | +24.7% | +15.2% | +0.8% |
| YoY Change | — | — | — | — | -54.8% | -32.4% | +18.0% | -32.4% | +509.6% | -31.8% | -50.0% | +12.0% | +177.9% | +56.4% | +76.0% | +70.5% | -87.4% | +49.9% | +35.3% | -13.1% |